Professor Yuval Garini heads the Nano Dynamics Lab in the Faculty of Biomedical Engineering and is affiliated with the Russell Berrie Nanotechnology Institute. He also serves as a Technion Faculty Ambassador.
Prof. Garini works in the areas of biophysics, digital pathology, chromatin and the nucleus and nano-scale biomolecules. Biophysics is an interdisciplinary science that tries to explain biological and medical phenomena using physical models. His research interests include genome organization in the nucleus, protein-DNA interaction, cancer genetics, spectral imaging, and nanoscience based on DNA origami (for drug delivery).
He is developing and using a broad range of experimental tools including optical microscopy, DNA origami, and single-molecule methods. In one project, he and his colleagues created a novel method to identify multiple biomarkers for cancer using optical spectral imaging systems. The detection of biomarkers is fundamental to the development of personalized cancer treatment protocols.
Prof. Garini lately established Pentaomix (Rehovot, Israel) for cancer detection and for matching the right drug to cancer patients, based on hyper-spectral imaging and AI. It is based on an optical imaging device that he invented. He holds 25 patents, and co-founder of Pentaomix.
Prof. Garini earned all three degrees in physics at the Technion. After finishing his Ph.D. in 1994, he spent few years at Applied Spectral Imaging, a company that develops advanced biomedical imaging where he invented Spectral Karyotyping, a method for screening genetic aberrations. He then joined and became a professor at Delft University in the Netherlands, and Bar-Ilan University before joining the Technion faculty in 2020.
